Annual review of KRAS inhibitors in 2022
Hao Wang, Lingling Chi, Fuqiang Yu, Honglin Dai, Chao Gao, Xiaojie Si, Zhengjie Wang, Limin Liu, Jiaxin Zheng, Lihong Shan, Hong‐Min Liu, Qiurong Zhang, Qiurong Zhang
Topics & Concepts
KRASCancer researchChemistryCancerComputational biologyBiologyColorectal cancerGeneticsProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysMelanoma and MAPK Pathways